T
42.15
11.45 (37.30%)
| Penutupan Terdahulu | 30.70 |
| Buka | 41.53 |
| Jumlah Dagangan | 12,066,897 |
| Purata Dagangan (3B) | 1,519,868 |
| Modal Pasaran | 3,887,981,568 |
| Harga / Pendapatan (P/E Ke hadapan) | 44.25 |
| Harga / Jualan (P/S) | 5.26 |
| Harga / Buku (P/B) | 23.30 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 30 Apr 2026 |
| Margin Keuntungan | -82.88% |
| Margin Operasi (TTM) | -52.21% |
| EPS Cair (TTM) | -2.78 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 97.50% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 1,220.07% |
| Nisbah Semasa (MRQ) | 2.05 |
| Aliran Tunai Operasi (OCF TTM) | -160.66 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -239.23 M |
| Pulangan Atas Aset (ROA TTM) | -23.21% |
| Pulangan Atas Ekuiti (ROE TTM) | -422.66% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menaik | Bercampur |
| Biotechnology (Global) | Menaik | Bercampur | |
| Stok | Travere Therapeutics, Inc. | Menurun | Menurun |
AISkor Stockmoo
-1.1
| Konsensus Penganalisis | -3.5 |
| Aktiviti Orang Dalam | -3.0 |
| Volatiliti Harga | -3.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | 4.0 |
| Purata | -1.10 |
|
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN) - rare kidney disorders that often cause end-stage kidney disease. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 0.75% |
| % Dimiliki oleh Institusi | 113.30% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Janus Henderson Group Plc | 31 Dec 2025 | 10,511,166 |
| Fmr Llc | 31 Dec 2025 | 9,617,863 |
| Nomura Investment Management Business Trust | 31 Dec 2025 | 3,773,564 |
| Armistice Capital, Llc | 31 Dec 2025 | 3,763,891 |
| Adage Capital Partners Gp, L.L.C. | 31 Dec 2025 | 2,927,000 |
| Renaissance Technologies Llc | 31 Dec 2025 | 2,246,779 |
| Rock Springs Capital Management Lp | 31 Dec 2025 | 2,210,322 |
| Geode Capital Management, Llc | 31 Dec 2025 | 2,143,495 |
| Goldman Sachs Group Inc | 31 Dec 2025 | 1,868,212 |
| Bank Of America Corp /De/ | 31 Dec 2025 | 1,850,355 |
| Stephens Investment Management Group Llc | 31 Dec 2025 | 1,721,623 |
| Julat 52 Minggu | ||
| Median | 38.00 (-9.85%) | |
| Jumlah | 1 Pegang | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Piper Sandler | 06 Feb 2026 | 38.00 (-9.85%) | Pegang | 29.71 |
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| DUBE ERIC M | - | 31.42 | -60,000 | -1,885,200 |
| REED ELIZABETH E | - | 31.42 | -10,000 | -314,200 |
| Jumlah Keseluruhan Kuantiti Bersih | -70,000 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -2,199,400 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 31.42 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| REED ELIZABETH E | Pegawai | 01 Apr 2026 | Jual automatik (-) | 10,000 | 31.42 | 314,200 |
| REED ELIZABETH E | Pegawai | 01 Apr 2026 | Pelaksanaan pilihan | 10,000 | - | - |
| DUBE ERIC M | Pegawai | 01 Apr 2026 | Jual automatik (-) | 60,000 | 31.42 | 1,885,200 |
| DUBE ERIC M | Pegawai | 01 Apr 2026 | Pelaksanaan pilihan | 60,000 | - | - |
| Tarikh | Jenis | Butiran |
|---|---|---|
| 04 Feb 2026 | Pengumuman | Travere Therapeutics to Present at the Guggenheim Emerging Outlook Biotech Summit |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |